Light-Induced Protein Degradation with Photocaged PROTACs

Xue, Gang, Wang, Kun, Zhou, Danli, Zhong, Hanbing, Pan, Zhengying·2019·Journal of the American Chemical Society
DOI 10.1021/jacs.9b06422

Cited by (384)

Items 201–300 of 384

  1. Light-inducible protein degradation in E. coli with the LOVdeg tag
    Nathan Tague, Cristian Coriano-Ortiz, Michael B. Sheets, Mary J. Dunlop · 2023 · eLife
  2. Flipping the Switch: Innovations in Inducible Probes for Protein Profiling
    Sean M. McKenna, Ellen M. Fay, Joanna F. McGouran · 2021 · ACS Chemical Biology
  3. Stimuli‐Responsive PROTACs for Controlled Protein Degradation
    Keli An, Xuqian Deng, Hongli Chi, Yuchao Zhang, Yan Li, Ming Cheng, Zhigang Ni, Zhi Yang, Chao Wang, Jinling Chen et al. · 2023 · Angewandte Chemie
  4. Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed
    Karim Kanbar, Roy El Darzi, Diana E. Jaalouk · 2024 · Frontiers in Genetics
  5. PROTACs: Novel approach for cancer breakdown by breaking proteins
    Humera Memon, Bhoomika M. Patel · 2022 · Life Sciences
  6. Bifunctional robots inducing targeted protein degradation
    Masilamani Elizabeth Sobhia, Harish Kumar, Sonia Kumari · 2023 · European Journal of Medicinal Chemistry
  7. FDA Approval of the First-Ever PROTAC: Vepdegestrant (ARV-471) Marks a New Era in Targeted Protein Degradation
    Anil Kumar, Saghir Ali, Qiang Shen, Jia Zhou · 2026 · Journal of Medicinal Chemistry
  8. Degraders on Demand: Engineering Smart Nanocarriers for PROTAC Delivery
    Antalin Casmie Amalraj, Vijaya Paspulathi Parthasarathy · 2025 · Molecular Pharmaceutics
  9. Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications
    Xingyu Jiang, Yinuo Chen, Yunna Gao, Rui Rong, Yi Lai, Zheying Zhu, Zhiai Xu · 2026 · Advanced Drug Delivery Reviews
  10. 131I Induced In Vivo Proteolysis by Photoswitchable azoPROTAC Reinforces Internal Radiotherapy
    Huihui Liu, Hehua Xiong, Changjun Li, Mengxia Xu, Yuyang Yun, Yiling Ruan, Lijun Tang, Tao Zhang, Dan Su, Xiaolian Sun · 2024 · Small
  11. In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
    Shaowen Xie, Jingjie Zhu, Yihan Peng, Fangyi Zhan, Feiyan Zhan, Chen He, Dazhi Feng, Jia Qing Xie, Jingyu Liu, Huajian Zhu et al. · 2024 · Angewandte Chemie
  12. Cascade-responsive nano-PROTACs for tumor-specific ALK protein degradation and enhanced cancer therapy
    Yanping Zhao, Junhui Sui, Jian Chang, Jianxiong Liu, Xiaoqian Wang, Hongjun Wang, Wei Chen, Binlong Chen, Yiguang Wang · 2025 · Nano Today
  13. In situ construction of intracellular supramolecular assemblies as an alternative strategy for protein degradation
    Xiaoqian Hu, Qingxin Yao, Xiaobo Wu, Jiali Chen, Ruijia Zhang, Yan Zhao, Yuan Gao · 2025 · Nature Communications
  14. Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
    Yang Gu-liang, Haiyan Zhong, Xinxin Xia, Zhiwen Qi, Chengzhang Wang, Shiming Li · 2021 · Food Science and Human Wellness
  15. Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders
    Ru Si, Nanxin Liu, Jin Wang, Qingqing Zhang, Yanchen Li, Xiaoyan Pan, Jie Zhang · 2022 · Bioorganic & Medicinal Chemistry
  16. From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors
    Mladen Koravović, Anand Mayasundari, Gordana Tasić, Fatemeh Keramatnia, Timothy R. Stachowski, Huarui Cui, Sergio C. Chai, Barbara Jonchère, Lei Yang, Yong Li et al. · 2023 · European Journal of Medicinal Chemistry
  17. Exploitation of Proximity-Mediated Effects in Drug Discovery: An Update of Recent Research Highlights in Perturbing Pathogenic Proteins and Correlated Issues
    Can Zhao, Henian Wang, Wenhu Zhan, Xiaoqing Lv, Xiaodong Ma · 2023 · Journal of Medicinal Chemistry
  18. Nanomotor‐Driven Targeting Chimeras as Accelerators for the Degradation of Extracellular Proteins
    Yujun Ning, Bin Li, Yixin Liu, Yanwei Lu, Xuedong Huang, Baohong Liu · 2024 · Small
  19. Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment
    Qixin Zhao, Rui Zeng, Tao Bi, Xuemei Yang, Ting Wang, Lei Chen, Juan Huang, Xiyu Dai, Houping Xu, Qin Sun et al. · 2025 · ACS Applied Materials & Interfaces
  20. Next‐Generation Proteolysis‐Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein Degradation
    Mohamed S. Nafie, Mohamed Khaled Diab, Asmaa S. A. Yassen, Amany M. Elshamy, Mohamed R. El Tohamy, Haytham O. Tawfik, Sherif Ashraf Fahmy · 2025 · Drug Development Research
  21. Spatiotemporal control of prodrug activation through external stimuli for effective and safe on-site release in solid tumors: From current advances to future perspectives
    Gabriele La Monica, Alessia Bono, Federica Alamia, Antonino Lauria, Annamaria Martorana · 2026 · Drug Discovery Today
  22. Photochemical Fingerprinting Is a Sensitive Probe for the Detection of Synthetic Cannabinoid Receptor Agonists; toward Robust Point-of-Care Detection
    Rachael C. Andrews, Benedict May, Federico J. Hernández, Gyles E. Cozier, Piers A. Townsend, Oliver B. Sutcliffe, Tom S. F. Haines, Tom P. Freeman, Jenny Scott, Stephen M. Husbands et al. · 2023 · Analytical Chemistry
  23. Delivering on Cell‐Selective Protein Degradation Using Chemically Tailored PROTACs
    Rui Yao, Tianli Luo, Ming Wang · 2023 · ChemBioChem
  24. PROTACs targeting epigenetic proteins
    Chao Zhang, Yuna He, Xiuyun Sun, Wenyi Wei, Yanlong Liu, Yu Rao · 2023 · Acta Materia Medica
  25. A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy
    Xuanrong Chen, Shen Haishan, Yi Shao, Qianwang Ma, Yuanjie Niu, Zhiqun Shang · 2021 · Translational Andrology and Urology
  26. Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains
    Chuhui Huang, Claire L. Harris, Ghizal Siddiqui, Manuela Jörg · 2025 · ACS Pharmacology & Translational Science
  27. Application of proteolysis targeting chimeric (PROTAC) technology in protein regulation and drug development
    Yiting He, Tianzuo Liao, Xuan'er Wang, Qian Hui Xiao, Hongmei Wang, Rui Rochelle He, Chenyu Zhao, Xinmiao Tian, Qinghua Gao, Liying Hao · 2025 · Bioorganic Chemistry
  28. Two Decades of Optogenetic Tools: A Retrospective and a Look Ahead
    Xiao Duan, Mo Zhu, Shiqiang Gao · 2025 · Advanced Genetics
  29. Synthetic approaches to constructing proteolysis targeting chimeras (PROTACs)
    Olga Bakulina, Alexander Sapegin, Alexander Siyasatovich Bunev, Mikhail Krasavin · 2022 · Mendeleev Communications
  30. PROTAC: A Novel Drug Delivery Technology for Targeting Proteins in Cancer Cells
    Rajni Bala, Rakesh Kumar Sindhu, Reecha Madaan, Shantanu K. Yadav · 2022 · Current Drug Discovery Technologies
  31. Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
    Soumik De, Raghaba Sahu, Shubhendu Palei, Laxmi Narayan Nanda · 2024 · Bioorganic & Medicinal Chemistry
  32. PROTAC technology for prostate cancer treatment
    Zhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, Wenyi Wei · 2025 · Acta Materia Medica
  33. The rise of targeting chimeras (TACs): next-generation medicines that preempt cellular events
    Scott A. Hollingsworth, Scott Arne Johnson, Pouyan Khakbaz, Yilin Meng, Varnavas D. Mouchlis, Olivia Pierce, Vera D. Prytkova, Erik Sebastian Vik, Dahlia R. Weiss, Veerabahu Shanmugasundaram · 2023 · Medicinal Chemistry Research
  34. PROTAC Degraders
    Alessio Ciulli, Oliver Hsia · 2022
  35. Targeted protein degradation with small molecules for cancer immunotherapy
    Zichao Yang, Jianwei Xu, Xixiang Yang, Jianjun Chen · 2025 · Asian Journal of Pharmaceutical Sciences
  36. Proteolysis-targeting chimera (PROTAC): A promising senolytic strategy
    Gang Fan, Qingping Zhang, W P Guo, Miao Liu, Dong Tan, Zhihan Tang, Jing Yang · 2026 · Ageing Research Reviews
  37. The Development and Application of Opto-Chemical Tools in the Zebrafish
    Zhiping Feng, Bertrand Ducos, Pierluigi Scerbo, Isabelle Aujard, Ludovic Jullien, David Bensimon · 2022 · Molecules
  38. On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence
    Thorsten Steinberg, Martin Philipp Dieterle, Imke Ramminger, Charlotte Klein, Julie Brossette, Ayman Husari, Pascal Tomakidi · 2023 · International Journal of Molecular Sciences
  39. PROTACs in Ovarian Cancer: Current Advancements and Future Perspectives
    Makenzie Vorderbruggen, Carlos A. Velázquez‐Martínez, Amarnath Natarajan, Adam R. Karpf · 2024 · International Journal of Molecular Sciences
  40. Recent breakthroughs in innovative elements, multidimensional enhancements, derived technologies, and novel applications of PROTACs
    Si-Han Zhang, Na Zeng, Jin‐Zhou Xu, Chen‐Qian Liu, Mengyao Xu, Jian‐Xuan Sun, Ye An, Xing‐Yu Zhong, Lin-Tao Miao, Shaogang Wang et al. · 2024 · Biomedicine & Pharmacotherapy
  41. Beute für das Proteasom: Gezielter Proteinabbau aus medizinalchemischer Perspektive
    Laura Martina Luh, Ulrike Scheib, Katrin Juenemann, Lars Wortmann, Michael Brands, Philipp M. Cromm · 2020 · Angewandte Chemie
  42. Recent Developments in Targeting Bromodomain and Extra Terminal Domain Proteins for Cancer Therapeutics
    Maohua Cai, Jinyun Dong, Haobin Li, Jiang‐Jiang Qin · 2022 · Current Medicinal Chemistry
  43. Major Advances in Emerging Degrader Technologies
    Hang Luo, Li Wu, Yujian He, Chong Qin, Xinjing Tang · 2022 · Frontiers in Cell and Developmental Biology
  44. Developing PROteolysis TArgeting Chimeras (PROTACs) for hematologic malignancies
    Yangping Wu, Jingliao Zhang, Xiaofan Zhu, Yingchi Zhang · 2022 · Cancer Letters
  45. Targeted Protein Degradation: Principles, Strategies, and Applications
    Ting He, Chenxi Wen, Guodong Yang, Xuekang Yang · 2023 · Advanced Biology
  46. Solid‐Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery
    Baoli Ding, Jiawen Hu, Rongtian Zhang, Binyan Shou, Mengdie Chen, Jiang Li, Meng Yuan, Bo Yang, Qiaojun He, Ji Cao et al. · 2025 · Angewandte Chemie International Edition
  47. Spatiotemporally controlled protein degradation via NIR-activatable PROTAC platform
    Nan Wang, Wei Cong, Yurui Zhu, Huaxing Shen, Chao Liu, Honggang Hu, Man Pan · 2025 · Science China Chemistry
  48. Design strategies and recent advances in activatable small molecule therapeutics
    Maurizio Giesler Garcia, Aliye Beyza Ozcelik, Emin Sahin, Filiz Girgin, Emine Buyuktokatli, Aleyna Karakaya, Mahmud Sacid Efe, Sündüs Erbaş-Çakmak · 2026 · Coordination Chemistry Reviews
  49. Linkerology in PROTACs: learnings for proximity-inducing therapeutics
    Rubén Prieto‐Díaz, Aina Urbina, Maria Rodriguez-Rios, Alessio Ciulli · 2026 · Trends in Biochemical Sciences
  50. Design and synthetic approaches to thalidomide based small molecule degraders
    Ajeet Kumar, Gulshan Kumar, Nidhi Kalia, Priya Ranjan Sahoo · 2025 · European Journal of Medicinal Chemistry
  51. PROTACs: A Hope for Breast Cancer Patients?
    Rajwinder Kaur, Gaurav Chaudhary, Amritpal Kaur, Pargat Singh, Gagan Deep Longowal, Gayatri P. Sapkale, Sandeep Arora · 2021 · Anti-Cancer Agents in Medicinal Chemistry
  52. Photorelease of Pyridines Using a Metal‐Free Photoremovable Protecting Group
    Xiao‐Jun Tang, Yayun Wu, Rong Zhao, Xiaolong Kou, Zaizai Dong, Wei Zhou, Zhen Zhang, Weihong Tan, Xiaohong Fang · 2020 · Angewandte Chemie
  53. Evolution of proteolysis-targeting chimeras (PROTAC) technology to overcome challenges of antimicrobial resistance
    Dhanashree N. Sarwan, Pramod Bhujangrao Khedekar, Ritesh P. Bhole, Rupesh V. Chikhale · 2025 · npj Antimicrobials and Resistance
  54. Advances in light-controllable PROTACs: Design strategies, therapeutic applications and current challenges
    Ji Wu, Ziyue Wang, Shi-Xuan Tan, Tingyu Li, Bingbing Chen, Qiqi Chen, Hao Li, Jin-Bo Niu, Xiang-Jing Fu, Jian Song et al. · 2025 · Bioorganic Chemistry
  55. Engineering Polymeric Nano-PROTAC for Targeted Protein Degradation and Cancer Therapy
    Madiha Saeed, Zainab Amina, Zhiai Xu, Haijun Yu · 2026 · Polymer science & technology.
  56. To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
    Diana Castagna, Benoit Gourdet, Roland Hjerpe, Philip MacFaul, Andrew Novak, Guillaume Révol, Étienne Rochette, Allan Michael Jordan · 2024 · Progress in medicinal chemistry
  57. Utilizing Alkyne‐Nitrone Cycloaddition for the Convenient Multi‐Component Assembly of Protein Degraders and Biological Probes
    Shiou‐Ting Lin, Chien‐Hua Wang, Ailin Chen, Tsung‐Shing Andrew Wang · 2024 · Chemistry - A European Journal
  58. Design of bifunctional molecules to accelerate post-translational modifications: achievements and challenges
    Yuxuan Wang, Yanyi He, Qidong You, Lei Wang · 2024 · Drug Discovery Today
  59. Light-induced modulation of DNA recognition by the Rad4/XPC damage sensor protein
    Amirrasoul Tavakoli, Debamita Paul, Hong Mu, Jagannath Kuchlyan, Saroj Baral, Anjum Ansari, Suse B. Broyde, Jung‐Hyun Min · 2021 · RSC Chemical Biology
  60. Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy
    Xu Zhang, Zhangzhi Song, Xinyu Zhang, Jianhua Zou, Guocan Yu, Xiaoyuan Shawn Chen, Sheng Wang · 2025 · Angewandte Chemie
  61. Current advances in the proteolysis-targeting chimeras (PROTACs) delivery systems
    Zhanzhan Feng, Shuyan Zhou, Xiao Li, Guoquan Wan, Kaiyan Xu, Zhiyong Qian · 2025 · Chinese Chemical Letters
  62. PROTAC-powered synergistic tumor therapy
    Xiaoyu Wang, Jingwen Zou, Yixuan Tao, Zhiwen Zhou, Changyu Bian, Zhiqiang Mao, Zhihong Liu · 2026 · TrAC Trends in Analytical Chemistry
  63. PROTACs in targeted protein degradation: Advances in development and AI-enhanced drug discovery
    Mao Du, Tao Liu, Wenyu Wang, Shuai Fan, Mei Tian, Qing Du, Zhidong Wang, Xiaodong Li, Xiaoyu Liu, Qin Xia et al. · 2026 · European Journal of Medicinal Chemistry Reports
  64. Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications
    Nikola Knoll, Nouri Neamati, Aykut Üren · 2026 · ACS Pharmacology & Translational Science
  65. O‐nitrobenzyl Caged Molecule Enables Photo‐controlled Release of Thiabendazole
    Wen Fu, Zhongli Shao, Zhiping Xu, Zhong Li, Xusheng Shao · 2024 · ChemBioChem
  66. Tandem‐Activatable PROTAC Prodrug for Tumor Biomarker‐Driven Near‐Infrared Opto‐Proteolysis
    Xiaoyan Lu, Xiaoning Wang, Hanwen Liao, Baitong Sha, Yan Zhang, Jinbo Li · 2025 · Angewandte Chemie
  67. Advances in controllable targeted protein degradation: emerging strategies and mechanisms
    Xiaoding Ma, Jianli Yin, Fan Ding, Guo Han, Xingwan Liu, Haifeng Ye · 2025 · Science China Life Sciences
  68. Design of RGD-functionalized GSH-responsive pegylated polymeric protacs for selective BRD4 degradation and EndMT-driven cardiac fibrosis inhibition
    Tao Bi, Lei Chen, Ting Wang, Wenjun Miao, Silong Zhai, Rui Huang, Qin Sun, Yuehua Chen, Hongna Su, Jie Zhou et al. · 2026 · Journal of Nanobiotechnology
  69. An ultrasound-activated PROTAC prodrug with self-reporting fluorescence for targeted protein degradation
    Tao Li, Yalan Tu, He Dong, Wenjiao Xie, Xiaoyu Pan, Youyong Yuan · 2026 · Biomaterials
  70. Targeted degradation of BRD4 by PROTACs: advances in cancer therapy
    Yanyun Hong, Xiang Liu, Yanfang Li, Mengting Yu, Caolin Wang, Cunpeng Nie, Shan Xu · 2026 · Chemical Communications
  71. Synthesis and preliminary anticancer evaluation of photo-responsive prodrugs of hydroxymethylene bisphosphonate alendronate
    Aurélie Descamps, Philippe Arnoux, Céline Frochot, Florent Barbault, Julia Deschamp, Maëlle Monteil, Evelyne Migianu‐Griffoni, Thibaut Legigan, Marc Lecouvey · 2024 · European Journal of Medicinal Chemistry
  72. Privileged Scaffolds Targeting Bromodomain-containing Protein 4
    Ru Wang, Yi-Ang Wang, Yungen Xu, Lei Shi · 2022 · Current Topics in Medicinal Chemistry
  73. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells
    Wen‐Ming Chen, Lu Zhang, Suling Liu, Ceshi Chen · 2022 · Cells
  74. Lighting the way to tumor destruction
    Christina C. Kuismi, Behnam Nabet · 2023 · Trends in Pharmacological Sciences
  75. Photopharmacology-based small-molecule Proteolysis Targeting Chimeras: Optical Control of Protein Degradation
    Wen Li, Reham M. Elhassan, Hao Fang, Xuben Hou · 2020 · Future Medicinal Chemistry
  76. Solid‐Phase Parallel Synthesis of Photocleavable Bifunctional Molecules Enables Efficient Phenotypic Protein Degrader Discovery
    Baoli Ding, Jiawen Hu, Rongtian Zhang, Binyan Shou, Mengdie Chen, Li Jiang, Meng Yuan, Bo Yang, Qiaojun He, Ji Cao et al. · 2025 · Angewandte Chemie
  77. Targeted protein degradation: therapeutic potential and challenges of PROTACs and molecular glues
    Sun Kim, Eui‐Bae Jeung · 2025 · Journal of Biomedical Translational Research
  78. Advances in light-activated PROTACs and phototherapy-combined approaches for cancer treatment
    Wei Zhang, Shuai Li, Hong Yuan, Jingyuan Zhao · 2025 · European Journal of Medicinal Chemistry
  79. Diversified design strategies for small-molecule PROTACs: How do we select?
    Qingsong Chen, Jian-Hua Liang · 2026 · European Journal of Medicinal Chemistry
  80. The HSP90-dependent bioorthogonal PROTAC prodrug system enables tumor-selective and enhanced protein degradation
    Fangkui Yin, Ting Song, Yang Song, Ke Wang, Hong Zhang, Maojun Jiang, Zihan Wang, Xiuwen Fan, Yanxin Zhang, Siyao Wang et al. · 2026 · Journal of Controlled Release
  81. Enzyme-Induced Supramolecular Proteolysis-Targeting Chimeras Enable Tumor-Targeted Protein Degradation
    Chunjing Liang, Xiaoqing Ma, Xiaxue Chen, Cunxun Dai, Xiaodi Sun, J S Li, 董如云, Peng Dong, Ming Wang · 2026 · JACS Au
  82. Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
    Tingting Yao, Zheng Zhou, Guangji Wang, Zhe-ying Zhu, Xi-Nuo Li · 2026 · Acta Pharmacologica Sinica
  83. New Generation of PROTACs: Advancement in Light‐Responsive and Self‐Assembled PROTACs
    Namrata Sapkota, Qi Xing, Jin Geng · 2024 · ChemistrySelect
  84. A Photocleavable Contrast Agent for Light-Responsive MRI
    Friederike Reeßing, Sèvrin E. M. Huijsse, Rudi Dierckx, Ben L. Feringa, Ronald Borra, Wiktor Szymański · 2020 · Pharmaceuticals
  85. Light inducible protein degradation in E. coli with the LOVdeg tag
    Nathan Tague, Cristian Coriano-Ortiz, Michael B. Sheets, Mary J. Dunlop · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Ubiquitination: A Double‐Edged Mechanism in Coronavirus Infections
    Sijie Liu, Chuhan Shao, Yina Ding, Yuxuan Wang, Liangyin Jin, De‐an Tan, Shanni Li, Xu Deng, Yuzheng Zhou, Zanxian Xia · 2025 · Journal of Medical Virology
  87. Biocompatible Chemistry: A Plug‐and‐Play Toolbox for Chemical Biology Research
    Adam R. Lovato, Lin Zeng, Qingfei Zheng · 2025 · ChemBioChem
  88. Near‐Infrared Light‐Activated Transcription Factor‐Targeted Proteolysis‐Targeting Chimeras Nanomachine for Targeted Degradation of Transcription Factors
    Bei Zhou, Junqing Yang, Bin Zhang, Weishan Wang, Jinbo Li, Yan Zhang · 2025 · ChemBioChem
  89. Advances in novel modification strategies for enhancing the tumor tissue specificity of PROTACs
    Liuzhi Hu, Shuang Wu, Wentao Wang, Hongbo He, Jinxin Che, Mingfei Wu, Xiaowu Dong · 2025 · European Journal of Medicinal Chemistry
  90. Dual / bifunctional targeting of bromodomain and extra-terminal (BET) proteins: Expanding the paradigm of epigenetic drug discovery
    Fuyang Jiang, Huili Li, Quan Sun, Jiandong Huang, Xianggui Chen, Qian Liang, Xueyuan Luo, Wenbao Zhang, Dandan He, Xiangchun Shen · 2025 · European Journal of Medicinal Chemistry
  91. Multi-stimuli activated PROTAC prodrug for controlled protein degradation with enhanced therapeutic effects
    Tianyang Zhou, Yibo Gao, Bohan Ma, Chi Wang, Shan Xu, Xiaoyu Feng, Bin Wang, Yanlin Jian, Lei Li · 2026 · European Journal of Medicinal Chemistry
  92. Nanoplatform‐Based Delivery Systems for PROTACs
    Wieqi Che, Xinlin Wang, Sijin Chen, Mao Du, Wenyu Wang, Dan Liu, Shuai Fan, Zundao Wu, Yi Wu, Yanbo Dong et al. · 2026 · Drug Development Research
  93. Targeted protein degradation: bridging chemical biology and clinical translation
    Yubo Zhang, Jun-wei Fu, Yue Liu, R Y Wu, Yanting Liang, Wei Zhang, Tao Yuan, Hao Zhu, Qiao-Jun He, Bo Yang · 2026 · Acta Pharmacologica Sinica
  94. Future of Trends in the Design and Development of PROTAC
    Popat Kumbhar, Kaustubh Ajit Kolekar, Vikas Kamble, Chukwuebuka Emmanuel Umeyor, John Disouza, Vandana Bharat Patravale · 2024 · Springer eBooks
  95. Photoswitchable Molecular Glues Enable Optical Control of Transcription Factor Degradation
    Christopher J. Arp, Martin Reynders, Vedagopuram Sreekanth, Praveen Kokkonda, Michele Pagano, Amit Choudhary, Dirk H. Trauner · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Enzyme‐Activated Orthogonal Proteolysis Chimeras for Tumor Microenvironment‐Responsive Immunomodulation
    Caixia Sun, Songhan Liu, Jun Wei Lau, Hanyu Yang, Yun Chen, Bengang Xing · 2025 · Angewandte Chemie
  97. Photocleavable PROTACs as tools for dynamic regulation of protein function
    Hanqiao Xu, Hidetomo Yokoo, Yosuke Demizu · 2025 · Bioorganic & Medicinal Chemistry
  98. Optical control of H1 receptor signaling with a BODIPY-photocaged antihistamine
    Ivana Josimovic, Yang Zheng, Zhiyong Wang, Tiffany van der Meer, Maikel Wijtmans, Henry F. Vischer, Rob Leurs · 2026 · Biochemical Pharmacology
  99. PROTAC-Mediated Targeted Degradation of MDM2 Induces Tumor-Suppressive Signaling in Osteosarcoma Cells
    Yeongji Kim, J E Kim, Junwon Choi, Jinhyeong Kim, Soyeon Park, Wonji Choi, Hyun‐Ju An, Jinman Kim, Minsup Kim, Sujin Choi et al. · 2026 · Cells
  100. Harnessing reactive oxygen species for precision medicine: ROS-Activatable PROTACs for lung Cancer
    Manuel Olazábal-Morán, C. Blázquez-Barbadillo, E. Pérez-Izquierdo, M. Muñoz-Silva, A. Garrido · 2026 · Advanced Drug Delivery Reviews